volume 7 issue 4 pages 389-409

The contribution of oxazolidinone frame to the biological activity of pharmaceutical drugs and natural products.

Publication typeJournal Article
Publication date2007-04-01
scimago Q2
wos Q3
SJR0.662
CiteScore8.5
Impact factor3.3
ISSN13895575, 18755607
Drug Discovery
General Medicine
Pharmacology
Abstract
The development of resistance by the antibiotics in the Gram-positive pathogenic bacteria over the last twenty years and continuing today has created a need for new antibiotic classes, which may be unaffected by existing bacterial resistance. The oxazolidin-2-ones represent not only a new class with a novel mechanism of action, but also satisfy the requirement for overcoming the resistance mechanisms. Both linezolid and eperozolid, the first chemical candidates, arose from the piperazine subclass, with the first one being chosen further development because of its enhanced pharmacokinetic properties. The main attractive traits of the oxazolidinone series has encouraged further work in the area, and the patent literature reveals that extensive chemical investigation is currently being made. The unexpected early resistance development emphasizes the need for further exploration of features of the oxazolidinone to eliminate these deficiencies. Recently, several changes, involving the C5 side chain as well the N-phenyl heterocyclic ring, give promise for such improvement. Oxazolidinone antibacterial agents comprise also ketolides, derivatives of macrolides, such as erythromycin A, with a newly formed carbamate cycle, with a largely unexplored potential. The oxazolidinone nucleus does not appear only in the structures of antimicrobial drugs, but a number of biological activities are connected with frameworks including the oxazolidinone ring. A partial list of these activities comprises enzyme inhibitors, agonists and antagonists, with a particular citation for a new generation of selective monoamino oxidase inhibitors (befloxatone). The oxazolidinone moiety was found in the structure of few biologically active natural products, such as (-)-cytoxazone and streptazolin. Moreover, in some cases the oxazolidinone ring has been chosen for the preparation of isosteric aza analogues of natural compounds (podophyllotoxin, pilocarpine) that can be more easily synthesised and more hardly inactivated. Finally, the participation of oxazolidinone chiral auxiliaries to several syntheses of natural products must be acknowledged.
Found 

Top-30

Journals

1
2
3
4
European Journal of Organic Chemistry
4 publications, 5.63%
Bulletin of the Korean Chemical Society
3 publications, 4.23%
Advanced Synthesis and Catalysis
3 publications, 4.23%
Tetrahedron Letters
2 publications, 2.82%
Bioorganic and Medicinal Chemistry Letters
2 publications, 2.82%
Organic Letters
2 publications, 2.82%
ACS Catalysis
2 publications, 2.82%
RSC Advances
2 publications, 2.82%
Synlett
2 publications, 2.82%
Synthesis
2 publications, 2.82%
ACS Applied Nano Materials
1 publication, 1.41%
Acta crystallographica. Section C, Structural chemistry
1 publication, 1.41%
Expert Opinion on Therapeutic Patents
1 publication, 1.41%
Chinese Journal of Organic Chemistry
1 publication, 1.41%
Pharmaceutics
1 publication, 1.41%
Frontiers in Public Health
1 publication, 1.41%
Environmental Chemistry Letters
1 publication, 1.41%
Russian Chemical Bulletin
1 publication, 1.41%
Applied Microbiology and Biotechnology
1 publication, 1.41%
Journal of Fuel Chemistry and Technology
1 publication, 1.41%
PLoS ONE
1 publication, 1.41%
Chinese Journal of Catalysis
1 publication, 1.41%
Trends in Pharmacological Sciences
1 publication, 1.41%
Tetrahedron
1 publication, 1.41%
Tetrahedron Asymmetry
1 publication, 1.41%
European Journal of Medicinal Chemistry
1 publication, 1.41%
Bioorganic and Medicinal Chemistry
1 publication, 1.41%
The Lancet Infectious Diseases
1 publication, 1.41%
Journal of Catalysis
1 publication, 1.41%
1
2
3
4

Publishers

2
4
6
8
10
12
14
16
18
Wiley
18 publications, 25.35%
Elsevier
17 publications, 23.94%
American Chemical Society (ACS)
9 publications, 12.68%
Springer Nature
5 publications, 7.04%
Royal Society of Chemistry (RSC)
5 publications, 7.04%
Georg Thieme Verlag KG
4 publications, 5.63%
MDPI
2 publications, 2.82%
International Union of Crystallography (IUCr)
1 publication, 1.41%
Taylor & Francis
1 publication, 1.41%
Shanghai Institute of Organic Chemistry
1 publication, 1.41%
Frontiers Media S.A.
1 publication, 1.41%
Public Library of Science (PLoS)
1 publication, 1.41%
Oxford University Press
1 publication, 1.41%
Hindawi Limited
1 publication, 1.41%
American Society for Microbiology
1 publication, 1.41%
European Journal of Chemistry
1 publication, 1.41%
Bentham Science Publishers Ltd.
1 publication, 1.41%
2
4
6
8
10
12
14
16
18
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
71
Share
Cite this
GOST |
Cite this
GOST Copy
Zappia G. et al. The contribution of oxazolidinone frame to the biological activity of pharmaceutical drugs and natural products. // Mini-Reviews in Medicinal Chemistry. 2007. Vol. 7. No. 4. pp. 389-409.
GOST all authors (up to 50) Copy
Zappia G. The contribution of oxazolidinone frame to the biological activity of pharmaceutical drugs and natural products. // Mini-Reviews in Medicinal Chemistry. 2007. Vol. 7. No. 4. pp. 389-409.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.2174/138955707780363783
UR - https://doi.org/10.2174/138955707780363783
TI - The contribution of oxazolidinone frame to the biological activity of pharmaceutical drugs and natural products.
T2 - Mini-Reviews in Medicinal Chemistry
AU - Zappia, Giovanni
PY - 2007
DA - 2007/04/01
PB - Bentham Science Publishers Ltd.
SP - 389-409
IS - 4
VL - 7
PMID - 17430225
SN - 1389-5575
SN - 1875-5607
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2007_Zappia,
author = {Giovanni Zappia},
title = {The contribution of oxazolidinone frame to the biological activity of pharmaceutical drugs and natural products.},
journal = {Mini-Reviews in Medicinal Chemistry},
year = {2007},
volume = {7},
publisher = {Bentham Science Publishers Ltd.},
month = {apr},
url = {https://doi.org/10.2174/138955707780363783},
number = {4},
pages = {389--409},
doi = {10.2174/138955707780363783}
}
MLA
Cite this
MLA Copy
Zappia, Giovanni, et al. “The contribution of oxazolidinone frame to the biological activity of pharmaceutical drugs and natural products..” Mini-Reviews in Medicinal Chemistry, vol. 7, no. 4, Apr. 2007, pp. 389-409. https://doi.org/10.2174/138955707780363783.
Profiles